News
Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...
The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's drug for patients with a rare and ...
The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's therapy for patients with a type of ...
1d
MedPage Today on MSNNext-Generation TKI Approved for Advanced ROS1-Positive Lung CancerThe FDA approved taletrectinib (Ibtrozi)-- a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) -- for the treatment ...
13h
Great Falls Tribune on MSNGreat Falls Hospital introduces new technology available in diagnosing lung cancerThe Ion robot from Intuitive is billed as offering a minimally invasive procedure for biopsies that can help with early ...
A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...
This weekend is graduation at Stanford. The keynote for Saturday’s medical school ceremony is a Stanford doctor, professor and now patient. Dr. Bryant Lin is fighting stage four lung cancer.
Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...
Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.
A new robotic tool at Houston Methodist Sugar Land can help doctors diagnose cancer earlier, hospital officials said in a ...
1d
News Medical on MSNScientists find unusual build-up of soot-like particles in lung cells of COPD patientsCells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of ...
The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results